| cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
| AA247719 | .e | 2315 to 2494 | 1 to 180 | 180/184 (97 %) | 1 diff (99.5 %id) | ||||
| AA749501 | brain | .d | 313 to 423 | 1 to 111 | 111/111 (100 %) | 0 diff (100 %id) | |||
| BP197115 | adrenal gland | .d | 34 to 610 | 1 to 577 | 577/582 (99 %) | 1 diff (99.9 %id) | |||
| AF161533 | blood | .j-u | 53 to 760 | 1 to 708 | A4R E6K A7P V8C P9L ... | 708/710 (99 %) | 4 diff (99.5 %id) | ||
| AF245436 | hypothalamus | .d | 48 to 2752 | 10 to 2713 | exact | tiling clone, | 2704/2717 (99 %) | 5 diff (99.9 %id) | |
| AJ708733 | heart | .d | 191 to 567 | 1 to 377 | 377/377 (100 %) | 0 diff (100 %id) | |||
| AK027171 | Human lung | .c | 1146 to 3070 | 1 to 1926 | tiling clone, available from FLJ, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 1926/1926 (100 %) | 2 diff (99.9 %id) | |
| AK056790 | placenta | .d | 34 to 2067 | 1 to 2034 | Q327R | available from FLJ, | 2034/2034 (100 %) | 1 diff (100.0 %id) | |
| AK074306 | .e | -8 to 2840 | 1 to 2848 | Q327R T338L H339I F340L E341K ... | tiling clone, available from FLJ, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 2848/2849 (99 %) | 10 diff (99.7 %id) | |
| AK313893 | cerebellum | .j-u | 20 to 473 | 1 to 453 | 453/453 (100 %) | 1 diff (99.8 %id) | |||
| AK314669 | cerebellum | .c | 322 to 2199 | 1 to 1878 | Q327R A346T | tiling clone, | 1878/1878 (100 %) | 2 diff (99.9 %id) | |
| AW837230 | leiomios | .l | 2258 to 2504 | 258 to 2 | 257/259 (99 %) | 0 diff (100 %id) | |||
| AW969031 | .e | 2152 to 2840 | 690 to 1 | Submitted on the opposite strand | 690/692 (99 %) | 10 diff (98.6 %id) | |||
| BC018663 | Muscle, rhabdomyosarcoma | .l | 1 to 2604 | 1 to 2604 | Q149E | tiling clone, available from MGC, AAA | 2604/2604 (100 %) | 2 diff (100.0 %id) | |
| BC033726 | Placenta, choriocarcinoma | .d | 226 to 2078 | 1 to 1853 | Q327R | available from MGC, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 1853/1853 (100 %) | 1 diff (100.0 %id) |
| BE005144 | breast_normal | .d | 554 to 867 | 16 to 329 | 314/329 (95 %) | 6 diff (98.2 %id) | |||
| BE181095 | head_neck | .d | 775 to 1078 | 28 to 333 | 306/333 (91 %) | 8 diff (97.6 %id) | |||
| BE835495 | prostate_normal | .e | 2244 to 2580 | 1 to 337 | 337/355 (94 %) | 3 diff (99.2 %id) | |||
| BG194403 | .e | 1907 to 2746 | 13 to 849 | 837/850 (98 %) | 17 diff (98.0 %id) | ||||
| DA042076 | bladder | .c | 248 to 822 | 2 to 577 | capped | 576/576 (100 %) | 1 diff (99.9 %id) | ||
| DA087228 | cerebellum | .c | 323 to 889 | 2 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | ||
| DA100353 | cerebellum | .j-u | 21 to 571 | 2 to 553 | E6G A7S V8R P9A P10S ... | capped | 552/552 (100 %) | 1 diff (99.9 %id) | |
| DA110658 | cerebellum | .d | 31 to 579 | 2 to 551 | capped | 550/550 (100 %) | 1 diff (99.9 %id) | ||
| DA129301 | alzheimer cortex | .d | 42 to 603 | 2 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | ||
| DA135337 | alzheimer cortex | .d | 598 to 1119 | 2 to 524 | capped | 523/524 (99 %) | 3 diff (99.5 %id) | ||
| DA180928 | amygdala | .d | 31 to 591 | 2 to 563 | capped | 562/562 (100 %) | 1 diff (99.9 %id) | ||
| DA232415 | brain | .d | 47 to 614 | 2 to 569 | capped | 568/568 (100 %) | 1 diff (99.9 %id) | ||
| DA232901 | brain | .n | 322 to 844 | 2 to 526 | tiling clone, capped | 525/525 (100 %) | 2 diff (99.7 %id) | ||
| DB305542 | brain | .n | 1576 to 2117 | 542 to 1 | tiling clone, | 542/542 (100 %) | 0 diff (100 %id) | ||
| DA249227 | brain | .j-u | 486 to 1086 | 2 to 602 | tiling clone, capped | 601/601 (100 %) | 0 diff (100 %id) | ||
| DA251031 | caudate nucleus | .d | 329 to 894 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
| DA269779 | caudate nucleus | .d | 49 to 597 | 2 to 550 | capped | 549/549 (100 %) | 1 diff (99.9 %id) | ||
| DA274888 | corpus callosum | .d | 35 to 599 | 2 to 567 | capped | 566/566 (100 %) | 1 diff (99.9 %id) | ||
| DA275858 | corpus callosum | .d | 47 to 597 | 2 to 552 | capped | 551/551 (100 %) | 1 diff (99.9 %id) | ||
| DA340628 | hippocampus | .j-u | 20 to 600 | 2 to 583 | E6G A7S V8R P9A P10S ... | capped | 582/582 (100 %) | 1 diff (99.9 %id) | |
| DA351791 | substantia nigra | .d | 589 to 1144 | 2 to 557 | capped | 556/556 (100 %) | 0 diff (100 %id) | ||
| DA395927 | thalamus | .d | 47 to 652 | 2 to 606 | capped | 605/607 (99 %) | 4 diff (99.4 %id) | ||
| BX098577 | ovarian tumor, ovary | .j-u | 804 to 1543 | 1 to 742 | 742/742 (100 %) | 2 diff (99.8 %id) | |||
| BX283136 | Burkitt lymphoma, lymph | .b | 196 to 706 | 1 to 511 | tiling clone, | 511/511 (100 %) | 0 diff (100 %id) | ||
| CB269161 | adipose | .d | 69 to 715 | 1 to 645 | 645/645 (100 %) | 2 diff (99.7 %id) | |||
| AF150137 | umbilical cord blood | .j-u | 53 to 760 | 1 to 708 | A4R E6K A7P V8C P9L ... | 708/710 (99 %) | 4 diff (99.5 %id) | ||
| AV735856 | cord Blood | .j-u | 51 to 495 | 44 to 477 | G3X K16F F17P P18R R19A ... | 434/482 (90 %) | 11 diff (97.8 %id) | ||
| BP216177 | corpus callosum | .d | 515 to 1096 | 1 to 583 | 583/583 (100 %) | 1 diff (99.9 %id) | |||
| CD700772 | normal nasopharynx | .d | 55 to 459 | 25 to 428 | 404/428 (94 %) | 7 diff (98.4 %id) | |||
| CD706697 | normal nasopharynx | .d | 50 to 476 | 14 to 440 | 427/440 (97 %) | 6 diff (98.7 %id) | |||
| CN277909 | embryonic stem cells, DMSO-treated H9 cellline | .p-u | 248 to 889 | 1 to 642 | exact | tiling clone, | 642/642 (100 %) | 4 diff (99.4 %id) | |
| CN336121 | embryonic stem cells, cell lines H1, H7, andH9 | .q | 1 to 751 | 1 to 751 | exact | tiling clone, | 751/751 (100 %) | 0 diff (100 %id) | |
| CN391270 | embryonic stem cells, DMSO-treated H9 cellline | .d | 66 to 255 | 1 to 190 | 190/190 (100 %) | 5 diff (97.4 %id) | |||
| CN391271 | embryonic stem cells, DMSO-treated H9 cellline | .s-u | 1 to 496 | 1 to 497 | exact | tiling clone, | 497/497 (100 %) | 1 diff (99.8 %id) | |
| CN391272 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .d | 110 to 603 | 1 to 494 | 494/494 (100 %) | 5 diff (99.0 %id) | |||
| BP219605 | caudate nucleus | .d | 1 to 583 | 1 to 582 | tiling clone, | 582/582 (100 %) | 2 diff (99.7 %id) | ||
| CR609047 | Placenta Cot 25-normalized | .a | 285 to 2922 | 1 to 2638 | exact | tiling clone, | 2638/2638 (100 %) | 0 diff (100 %id) | |
| CR736750 | .d | 1400 to 1892 | 1 to 493 | 493/493 (100 %) | 1 diff (99.8 %id) | ||||
| AL552045 | placenta, Placenta Cot 25-normalized | .d | 96 to 1182 | 1 to 1077 | 1077/1079 (99 %) | 26 diff (97.6 %id) | |||
| AL575568 | placenta, Placenta Cot 25-normalized | .e | 1908 to 2812 | 916 to 16 | 901/1093 (82 %) | 0 diff (100 %id) | |||
| BX327904 | Placenta Cot 25-normalized | .d | 926 to 1807 | 1 to 882 | 882/882 (100 %) | 16 diff (98.2 %id) | |||
| BX327905 | Placenta Cot 25-normalized | .d | 928 to 1792 | 1 to 847 | 847/856 (98 %) | 23 diff (97.4 %id) | |||
| BX371808 | Placenta Cot 25-normalized | .d | 1028 to 1885 | 866 to 8 | 859/870 (98 %) | 7 diff (99.2 %id) | |||
| BX371809 | Placenta Cot 25-normalized | .d | 1025 to 1901 | 877 to 1 | 877/877 (100 %) | 8 diff (99.1 %id) | |||
| CV027557 | mixed | .d | 241 to 807 | 1 to 566 | 566/566 (100 %) | 2 diff (99.7 %id) | |||
| AL599402 | .n | 53 to 540 | 1 to 488 | exact | tiling clone, | 488/488 (100 %) | 1 diff (99.8 %id) | ||
| BX509709 | .j-u | -9 to 744 | 1 to 754 | exact | tiling clone, | 754/759 (99 %) | 3 diff (99.7 %id) | ||
| AL700118 | human skeletal muscle | .d | 511 to 1172 | 1 to 665 | 665/668 (99 %) | 9 diff (98.7 %id) | |||
| AL706820 | human skeletal muscle | .j-u | 43 to 664 | 1 to 623 | W24C A25S | 623/623 (100 %) | 13 diff (98.0 %id) | ||
| BX476818 | .c | 1 to 458 | 1 to 458 | tiling clone, | 458/458 (100 %) | 0 diff (100 %id) | |||
| BX491719 | .j-u | 18 to 511 | 1 to 494 | exact | 494/494 (100 %) | 3 diff (99.4 %id) | |||
| BX955653 | .j-u | 1 to 412 | 4 to 415 | 415/415 (100 %) | 2 diff (99.6 %id) | ||||
| BX494068 | .j-u | 32 to 557 | 1 to 526 | exact | 526/531 (99 %) | 4 diff (99.3 %id) | |||
| DW408004 | Liver | .d | 176 to 558 | 437 to 55 | 383/449 (85 %) | 1 diff (99.8 %id) | |||
| DW419038 | Liver | .d | 69 to 463 | 16 to 410 | 395/410 (96 %) | 14 diff (96.6 %id) | |||
| DW442813 | Liver | .d | 72 to 296 | 10 to 233 | 224/233 (96 %) | 9 diff (96.2 %id) | |||
| ES315757 | melanoma cell line | .o | 236 to 547 | 345 to 34 | exact | Submitted on the opposite strand | 312/381 (81 %) | 0 diff (100 %id) | |
| BP230427 | brain | .j-u | 239 to 740 | 1 to 502 | 502/581 (86 %) | 19 diff (96.8 %id) | |||
| FN152590 | breast carcinoma | .e | 2360 to 2463 | 1 to 105 | 105/105 (100 %) | 1 diff (99.1 %id) | |||
| GD139177 | .e | 1930 to 2021 | 92 to 1 | Submitted on the opposite strand | 92/103 (89 %) | 1 diff (99.1 %id) | |||
| D81097 | brain | .e | 2564 to 2840 | 1 to 277 | 277/277 (100 %) | 0 diff (100 %id) | |||
| AV691095 | hepatocellular carcinoma | .k | 1 to 409 | 1 to 346 | exact | tiling clone, | Suspected internal deletion | 346/349 (99 %) | 11 diff (96.9 %id) |
| AV719519 | corresponding non cancerous liver tissue | .l | 650 to 1238 | 589 to 1 | Submitted on the opposite strand | 589/589 (100 %) | 5 diff (99.2 %id) | ||
| DB451173 | testis | .d | 45 to 532 | 1 to 488 | 488/488 (100 %) | 0 diff (100 %id) | |||
| DB516664 | testis | .e | 2397 to 2840 | 1 to 444 | Submitted on the opposite strand | 444/444 (100 %) | 1 diff (99.8 %id) | ||
| DB472544 | hippocampus | .n | 1 to 487 | 6 to 492 | exact | tiling clone, | 492/492 (100 %) | 2 diff (99.6 %id) | |
| DB541305 | hippocampus | .e | 2381 to 2843 | 1 to 463 | Submitted on the opposite strand | 463/463 (100 %) | 1 diff (99.8 %id) | ||
| T27284 | .d | 219 to 412 | 5 to 199 | 195/199 (97 %) | 6 diff (97.0 %id) | ||||
| T27346 | .t | 1 to 244 | 1 to 244 | K14X Q36X E54X E62X | tiling clone, | 244/244 (100 %) | 1 diff (99.6 %id) | ||
| BP234070 | coronary artery | .d | 46 to 625 | 1 to 581 | 581/581 (100 %) | 9 diff (98.5 %id) | |||
| BP236944 | coronary artery | .d | 46 to 628 | 1 to 583 | 583/583 (100 %) | 2 diff (99.7 %id) | |||
| DA569331 | whole embryo, mainly head | .b | 352 to 1132 | 2 to 784 | tiling clone, capped | 783/820 (95 %) | 9 diff (99.0 %id) | ||
| DB355958 | whole embryo, mainly head | .b | 1810 to 2378 | 570 to 1 | tiling clone, | 570/570 (100 %) | 16 diff (97.2 %id) | ||
| BP241169 | Liver | .e | 1 to 503 | 9 to 511 | 511/554 (92 %) | 7 diff (98.8 %id) | |||
| AV723811 | hypothalamus | .e | 2180 to 2843 | 15 to 672 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 658/672 (97 %) | 6 diff (99.2 %id) | |
| AV721062 | hypothalamus | .d | 48 to 572 | 1 to 525 | 525/531 (98 %) | 1 diff (99.9 %id) | |||
| R68789 | placenta | .e | 2547 to 2836 | 290 to 1 | fully sequenced, | 290/290 (100 %) | 7 diff (97.6 %id) | ||
| R68889 | placenta | .e | 2176 to 2559 | 1 to 391 | fully sequenced, | 391/391 (100 %) | 12 diff (97.0 %id) | ||
| R72970 | placenta | .e | 2176 to 2494 | 1 to 324 | 324/324 (100 %) | 6 diff (98.2 %id) | |||
| R73585 | placenta | .e | 2601 to 2828 | 228 to 1 | 228/238 (95 %) | 1 diff (99.6 %id) | |||
| H01529 | placenta | .e | 2644 to 2827 | 184 to 1 | 184/184 (100 %) | 0 diff (100 %id) | |||
| H01638 | placenta | .e | 2176 to 2521 | 1 to 357 | 357/395 (90 %) | 17 diff (95.7 %id) | |||
| H87507 | placenta | .d | 1199 to 1568 | 1 to 374 | 374/374 (100 %) | 5 diff (98.7 %id) | |||
| H87508 | placenta | .d | 2552 to 2720 | 170 to 1 | 170/179 (94 %) | 1 diff (99.5 %id) | |||
| N49389 | multiple sclerosis lesions | .o | 943 to 1332 | 394 to 1 | tiling clone, | 394/486 (81 %) | 7 diff (98.6 %id) | ||
| N49478 | multiple sclerosis lesions | .o | 244 to 596 | 1 to 354 | exact | 354/354 (100 %) | 3 diff (99.2 %id) | ||
| AA056754 | uterus | .d | 2485 to 2746 | 275 to 13 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 263/263 (100 %) | 1 diff (99.7 %id) | |
| AA058432 | uterus | .d | 1504 to 1884 | 1 to 393 | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 393/393 (100 %) | 9 diff (97.8 %id) | ||
| AA287382 | germinal center B cell | .e | 2460 to 2842 | 383 to 1 | fully sequenced, | 383/383 (100 %) | 0 diff (100 %id) | ||
| AA287509 | germinal center B cell | .e | 2118 to 2490 | 1 to 373 | fully sequenced, | 373/373 (100 %) | 0 diff (100 %id) | ||
| AA293376 | ovarian tumor, ovary | .j-u | 804 to 1262 | 1 to 459 | 459/459 (100 %) | 0 diff (100 %id) | |||
| AA398523 | ovarian tumor, ovary | .p-u | 36 to 460 | 425 to 1 | 425/425 (100 %) | 0 diff (100 %id) | |||
| AI820906 | ovarian tumor, ovary | .j-u | 804 to 1332 | 1 to 529 | tiling clone, | 529/529 (100 %) | 0 diff (100 %id) | ||
| AI821542 | ovarian tumor, ovary | .p-u | 1 to 460 | 460 to 1 | tiling clone, | 460/460 (100 %) | 0 diff (100 %id) | ||
| AA406109 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .o | 286 to 657 | 374 to 3 | exact | 372/374 (99 %) | 0 diff (100 %id) | ||
| AA478080 | ovarian tumor, ovary | .e | 2040 to 2435 | 1 to 396 | 396/396 (100 %) | 0 diff (100 %id) | |||
| AA496142 | .d | 1427 to 1651 | 1 to 225 | fully sequenced, | 225/225 (100 %) | 0 diff (100 %id) | |||
| AA496143 | .d | 1590 to 2073 | 486 to 3 | fully sequenced, | 484/486 (99 %) | 0 diff (100 %id) | |||
| AA451627 | .d | 1329 to 1798 | 1 to 470 | 470/470 (100 %) | 0 diff (100 %id) | ||||
| AA504417 | germinal center B cell | .o | 316 to 782 | 1 to 466 | exact | 466/466 (100 %) | 1 diff (99.8 %id) | ||
| AA683003 | schizophrenic brain S-11 frontal lobe | .d | 761 to 1096 | 1 to 336 | Submitted on the opposite strand | 336/336 (100 %) | 2 diff (99.5 %id) | ||
| AA652789 | .e | 1960 to 2301 | 8 to 349 | 342/354 (96 %) | 1 diff (99.8 %id) | ||||
| AA714205 | germinal center B-cells, tonsil | .d | 1595 to 2067 | 483 to 11 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 473/473 (100 %) | 0 diff (100 %id) | |
| AA744791 | germinal center B cell | .e | 1919 to 2303 | 393 to 9 | 385/393 (97 %) | 0 diff (100 %id) | |||
| AA720647 | germinal center B cell | .o | 333 to 650 | 318 to 1 | 318/318 (100 %) | 0 diff (100 %id) | |||
| AA768873 | germinal center B cell | .e | 2378 to 2840 | 493 to 31 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 463/463 (100 %) | 0 diff (100 %id) | |
| AA808380 | germinal center B cell | .e | 2410 to 2850 | 458 to 22 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 437/471 (92 %) | 0 diff (100 %id) | |
| AA906927 | pooled | .d | 1805 to 2021 | 217 to 1 | 217/217 (100 %) | 0 diff (100 %id) | |||
| AA975521 | carcinoid, lung | .e | 2357 to 2840 | 484 to 1 | 484/484 (100 %) | 0 diff (100 %id) | |||
| AI205111 | schizophrenic brain S-11 frontal lobe | .d | 1085 to 1428 | 345 to 2 | 344/345 (99 %) | 2 diff (99.5 %id) | |||
| AI129332 | uterus | .e | 1986 to 2387 | 431 to 30 | 402/431 (93 %) | 0 diff (100 %id) | |||
| AI215982 | pooled | .e | 2444 to 2848 | 406 to 1 | 406/406 (100 %) | 1 diff (99.8 %id) | |||
| AI286012 | pooled | .d | 1583 to 2066 | 486 to 3 | 484/486 (99 %) | 0 diff (100 %id) | |||
| AI286073 | pooled | .o | 235 to 650 | 418 to 3 | exact | 416/418 (99 %) | 0 diff (100 %id) | ||
| AI476316 | follicular lymphoma, lymph node | .e | 2365 to 2844 | 480 to 1 | 480/480 (100 %) | 0 diff (100 %id) | |||
| AI569569 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .e | 2346 to 2842 | 497 to 1 | 497/497 (100 %) | 2 diff (99.6 %id) | |||
| AI569330 | adenocarcinoma, Pancreas | .e | 2484 to 2842 | 359 to 1 | 359/359 (100 %) | 0 diff (100 %id) | |||
| AI784410 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .e | 2522 to 2848 | 327 to 1 | 327/327 (100 %) | 0 diff (100 %id) | |||
| AI685337 | pooled | .e | 2394 to 2842 | 449 to 1 | 449/449 (100 %) | 0 diff (100 %id) | |||
| AI697737 | carcinoid, lung | .e | 2365 to 2840 | 476 to 1 | 476/476 (100 %) | 5 diff (99.0 %id) | |||
| AW071692 | anaplastic oligodendroglioma, brain | .e | 2281 to 2840 | 562 to 1 | 562/562 (100 %) | 2 diff (99.7 %id) | |||
| AW303806 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .e | 2434 to 2843 | 410 to 1 | 410/410 (100 %) | 0 diff (100 %id) | |||
| AW301603 | Kidney | .e | 2398 to 2848 | 451 to 1 | tiling clone, | 451/451 (100 %) | 0 diff (100 %id) | ||
| AW338565 | adenocarcinoma, Pancreas | .e | 2597 to 2841 | 264 to 1 | 264/264 (100 %) | 24 diff (91.0 %id) | |||
| AW473390 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .e | 2365 to 2842 | 480 to 3 | 478/480 (99 %) | 0 diff (100 %id) | |||
| AW341557 | pooled | .e | 2364 to 2840 | 477 to 1 | 477/477 (100 %) | 3 diff (99.4 %id) | |||
| AW593323 | pooled | .d | 1591 to 2068 | 480 to 3 | 478/480 (99 %) | 0 diff (100 %id) | |||
| AW411538 | muscle, rhabdomyosarcoma | .d | 88 to 723 | 8 to 643 | 636/643 (98 %) | 1 diff (99.9 %id) | |||
| BE041750 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .e | 2502 to 2843 | 346 to 1 | 346/346 (100 %) | 6 diff (98.3 %id) | |||
| BF515831 | .e | 2387 to 2840 | 472 to 18 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 455/455 (100 %) | 7 diff (98.5 %id) | ||
| BE219222 | carcinoid, lung | .e | 2320 to 2840 | 533 to 13 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 521/521 (100 %) | 0 diff (100 %id) | |
| BE538838 | cervix | .l | 1401 to 2043 | 1 to 645 | 645/645 (100 %) | 16 diff (97.6 %id) | |||
| BE513259 | Burkitt lymphoma, lymph | .b | 215 to 860 | 1 to 640 | 640/734 (87 %) | 12 diff (98.4 %id) | |||
| BF032069 | hypernephroma, Kidney | .e | 2312 to 2827 | 1 to 513 | 513/755 (67 %) | 16 diff (97.9 %id) | |||
| BE737698 | brain, glioblastoma | .o | 323 to 805 | 1 to 483 | exact | 483/483 (100 %) | 1 diff (99.8 %id) | ||
| BE738670 | brain, glioblastoma | .e | 2021 to 2800 | 784 to 1 | 784/785 (99 %) | 24 diff (97.0 %id) | |||
| BF185746 | brain, glioblastoma | .d | 1604 to 2275 | 1 to 664 | 664/882 (75 %) | 17 diff (98.1 %id) | |||
| BF207441 | bladder, carcinoma, cell line | .h | 16 to 489 | 1 to 474 | tiling clone, | 474/474 (100 %) | 3 diff (99.4 %id) | ||
| BF526442 | brain, glioblastoma with EGFR amplification | .d | 1570 to 2357 | 1 to 791 | 789/834 (94 %) | 48 diff (94.3 %id) | |||
| BF572784 | melanotic melanoma, high MDR, skin | .e | 2270 to 2834 | 1 to 586 | AAA | 586/890 (65 %) | 65 diff (92.7 %id) | ||
| BF573484 | melanotic melanoma, high MDR, skin | .e | 2316 to 2850 | 1 to 541 | 541/633 (85 %) | 21 diff (96.7 %id) | |||
| BF691470 | melanotic melanoma, high MDR, skin | .e | 2270 to 2850 | 1 to 577 | 577/719 (80 %) | 9 diff (98.8 %id) | |||
| BG033369 | breast, mammary adenocarcinoma, cell line | .d | 1538 to 2221 | 1 to 687 | 687/785 (87 %) | 10 diff (98.8 %id) | |||
| BG034082 | breast, mammary adenocarcinoma, cell line | .l | 2521 to 2917 | 1 to 397 | tiling clone, AAA | 397/397 (100 %) | 0 diff (100 %id) | ||
| BG167304 | hypernephroma, cell line, Kidney | .l | 617 to 1299 | 1 to 685 | 685/1222 (56 %) | 13 diff (99.0 %id) | |||
| BG285796 | bladder, transitional cell papilloma, cell line | .d | 1257 to 1953 | 1 to 697 | 697/697 (100 %) | 35 diff (95.0 %id) | |||
| BG390443 | embryonal carcinoma, cell line, testis | .g | 1 to 804 | 1 to 811 | N199T F215L A216R D217I Y218T ... | tiling clone, | 811/867 (93 %) | 34 diff (96.1 %id) | |
| BG500307 | adenocarcinoma, Prostate | .e | 2160 to 2829 | 1 to 669 | 669/669 (100 %) | 7 diff (99.0 %id) | |||
| BG501336 | adenocarcinoma, Prostate | .l | 2090 to 2781 | 1 to 693 | 693/693 (100 %) | 7 diff (99.0 %id) | |||
| BG533681 | Liver | .e | 2057 to 2839 | 1 to 777 | 777/777 (100 %) | 23 diff (97.1 %id) | |||
| BG568488 | Liver | .a | 1 to 646 | 1 to 646 | tiling clone, | 646/646 (100 %) | 0 diff (100 %id) | ||
| BG570666 | lung | .h | 1 to 697 | 1 to 699 | Q62R F197S V199G G200W R201Q ... | tiling clone, | 699/881 (79 %) | 9 diff (99.0 %id) | |
| BG617599 | Liver | .e | 2155 to 2779 | 1 to 627 | AAA | 627/727 (86 %) | 7 diff (99.1 %id) | ||
| BG683356 | brain, neuroblastoma, cell line | .d | 67 to 751 | 1 to 679 | 679/680 (99 %) | 13 diff (98.1 %id) | |||
| BG779438 | adenocarcinoma, Prostate | .d | 1538 to 2190 | 1 to 654 | 654/655 (99 %) | 6 diff (99.1 %id) | |||
| BG778780 | adenocarcinoma, Prostate | .d | 1538 to 2161 | 1 to 624 | 624/624 (100 %) | 2 diff (99.7 %id) | |||
| BI093020 | cervix | .d | 1217 to 1995 | 12 to 793 | 780/802 (97 %) | 23 diff (97.2 %id) | |||
| BI092761 | cervix | .e | 2711 to 2840 | 1 to 130 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 130/130 (100 %) | 1 diff (99.3 %id) | |
| BI094276 | cervix | .d | 220 to 966 | 5 to 747 | 743/747 (99 %) | 7 diff (99.1 %id) | |||
| BI818521 | pooled brain, lung, testis | .d | 181 to 765 | 126 to 717 | 598/717 (83 %) | 59 diff (91.8 %id) | |||
| BM559348 | amelanotic melanoma, cell line, skin | .l | 1978 to 2604 | 1 to 627 | AAA | 627/627 (100 %) | 1 diff (99.9 %id) | ||
| CA334825 | posterior tongue (pooled) | .e | 1989 to 2616 | 1 to 628 | tiling clone, | 628/628 (100 %) | 0 diff (100 %id) | ||
| BU159905 | eye, retinoblastoma | .d | 71 to 978 | 1 to 916 | 916/933 (98 %) | 29 diff (96.9 %id) | |||
| BU567281 | testis | .i | 5 to 682 | 1 to 686 | 686/739 (92 %) | 20 diff (97.3 %id) | |||
| BU567889 | testis | .d | 1247 to 2046 | 1 to 803 | 803/807 (99 %) | 13 diff (98.4 %id) | |||
| BU568246 | testis | .i | 5 to 788 | 1 to 798 | AAA | 798/804 (99 %) | 40 diff (95.1 %id) | ||
| BU568936 | testis | .i | 5 to 678 | 1 to 685 | 685/835 (82 %) | 20 diff (97.7 %id) | |||
| BU570007 | testis | .i | 1 to 788 | 1 to 787 | exact | tiling clone, | 787/790 (99 %) | 10 diff (98.8 %id) | |
| BU852475 | testis | .i | 5 to 662 | 1 to 662 | 662/773 (85 %) | 11 diff (98.6 %id) | |||
| BU852988 | testis | .i | 5 to 643 | 1 to 640 | 640/810 (79 %) | 14 diff (98.3 %id) | |||
| BU854084 | testis | .i | 5 to 742 | 1 to 737 | tiling clone, | 737/737 (100 %) | 8 diff (99.0 %id) | ||
| BU854368 | testis | .i | 5 to 767 | 1 to 766 | tiling clone, | 766/766 (100 %) | 14 diff (98.2 %id) | ||
| CX787754 | human embryonic stem cells | .j-u | 1192 to 2003 | 1 to 812 | tiling clone, | 812/812 (100 %) | 0 diff (100 %id) | ||
| CD558090 | testis | .f | 1 to 871 | 29 to 904 | T231N L232I A233S A234C Q235T ... | tiling clone, | 876/905 (96 %) | 17 diff (98.2 %id) | |
| TI_57196415 | .d | 181 to 765 | 156 to 747 | 598/747 (80 %) | 59 diff (92.2 %id) | ||||
| BP279499 | .b | 1 to 574 | 1 to 574 | tiling clone, | 574/583 (98 %) | 5 diff (99.2 %id) | |||
| CB135156 | Liver | .d | 1175 to 1678 | 1 to 504 | 504/504 (100 %) | 2 diff (99.7 %id) | |||
| BP292243 | lung | .d | 822 to 1398 | 1 to 578 | 578/579 (99 %) | 6 diff (99.0 %id) | |||
| NM_024725.3 | .d | 27 to 2754 | 1 to 2728 | exact | RefSeq, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 2728/2728 (100 %) | 0 diff (100 %id) | |
| AV750824 | Pituitary | .d | 221 to 620 | 1 to 396 | 396/404 (98 %) | 5 diff (98.8 %id) | |||
| BP311553 | brain | .d | 46 to 617 | 1 to 572 | 572/582 (98 %) | 2 diff (99.7 %id) | |||
| DA715681 | .d | 539 to 1089 | 2 to 552 | capped | 551/551 (100 %) | 1 diff (99.9 %id) | |||
| DA746023 | .d | 784 to 1358 | 2 to 577 | capped | 576/576 (100 %) | 1 diff (99.9 %id) | |||
| DA752670 | .d | 35 to 613 | 2 to 580 | capped | 579/579 (100 %) | 0 diff (100 %id) | |||
| DA801410 | brain | .r | 1 to 542 | 2 to 544 | L19X R20A D21* | tiling clone, capped | 543/550 (98 %) | 3 diff (99.5 %id) | |
| DA815012 | .d | 80 to 638 | 2 to 559 | capped | 558/558 (100 %) | 2 diff (99.7 %id) | |||
| DA830859 | placenta | .d | 82 to 800 | 2 to 729 | capped | 728/731 (99 %) | 12 diff (98.4 %id) | ||
| DB376220 | placenta | .d | 1874 to 2291 | 423 to 1 | 423/425 (99 %) | 11 diff (97.5 %id) | |||
| DA838186 | placenta | .d | 35 to 595 | 2 to 562 | capped | 561/561 (100 %) | 0 diff (100 %id) | ||
| DB328315 | placenta | .d | 1525 to 2067 | 543 to 1 | 543/543 (100 %) | 0 diff (100 %id) | |||
| BP327596 | prostata | .d | 71 to 641 | 1 to 570 | 570/570 (100 %) | 6 diff (99.0 %id) | |||
| DA888676 | .d | 82 to 646 | 2 to 566 | capped | 565/565 (100 %) | 0 diff (100 %id) | |||
| BM832840 | stomach | .o | 263 to 905 | 1 to 642 | exact | tiling clone, | 642/642 (100 %) | 2 diff (99.7 %id) | |
| BM838965 | stomach | .e | 1906 to 2428 | 1 to 522 | 522/522 (100 %) | 1 diff (99.9 %id) | |||
| TI_1948075263 | .l | 617 to 1183 | 704 to 120 | 585/1397 (41 %) | 42 diff (97.0 %id) | ||||
| TI_1948075264 | .l | 403 to 1183 | 898 to 121 | 778/1108 (70 %) | 56 diff (95.0 %id) | ||||
| TI_1948075566 | .l | 400 to 1183 | 902 to 126 | 777/1087 (71 %) | 48 diff (95.6 %id) | ||||
| TI_1948075834 | .l | 539 to 1183 | 793 to 131 | 663/1159 (57 %) | 30 diff (97.5 %id) | ||||
| TI_1948076106 | .l | 535 to 1183 | 781 to 130 | 652/1149 (56 %) | 34 diff (97.1 %id) | ||||
| BP337071 | coronary artery | .d | 48 to 630 | 1 to 584 | 584/584 (100 %) | 2 diff (99.7 %id) | |||
| BP351600 | .d | 115 to 705 | 1 to 588 | 590/588 (100 %) | 5 diff (99.2 %id) | ||||
| DN992578 | brain, whole brain | .d | 613 to 1227 | 9 to 624 | 616/624 (98 %) | 7 diff (98.9 %id) | |||
| DB058044 | testis | .d | 35 to 570 | 2 to 537 | capped | 536/536 (100 %) | 0 diff (100 %id) | ||
| DB119595 | thymus | .d | 631 to 1168 | 2 to 539 | capped | 538/538 (100 %) | 0 diff (100 %id) | ||
| TI_149280055 | .e | 2060 to 2840 | 909 to 131 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 779/785 (99 %) | 0 diff (100 %id) | ||
| TI_149291739 | .d | 1363 to 2069 | 780 to 80 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 701/702 (99 %) | 7 diff (99.1 %id) | ||
| TI_154009452 | .e | 2232 to 2843 | 706 to 95 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 612/1001 (61 %) | 1 diff (100.0 %id) | ||
| TI_154017013 | .o | 1 to 649 | 760 to 97 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 664/724 (91 %) | 21 diff (97.1 %id) | |
| DB175947 | kidney, tumor tissue | .d | 35 to 613 | 2 to 580 | capped | 579/579 (100 %) | 0 diff (100 %id) | ||
| DB243223 | stomach, tumor tissue | .m | 1 to 578 | 2 to 580 | exact | tiling clone, capped | 579/579 (100 %) | 1 diff (99.9 %id) | |
| BQ022403 | placenta | .e | 2515 to 2840 | 344 to 18 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 327/336 (97 %) | 2 diff (99.5 %id) | |
| BQ025290 | placenta | .e | 2179 to 2840 | 679 to 19 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 661/662 (99 %) | 1 diff (99.9 %id) | |
| BQ011625 | placenta | .o | 244 to 653 | 426 to 17 | exact | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 410/410 (100 %) | 0 diff (100 %id) |
| BU682158 | lung | .d | 1434 to 2069 | 649 to 17 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 633/633 (100 %) | 3 diff (99.6 %id) | |
| BM678039 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 2053 to 2749 | 711 to 16 | tiling clone, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 696/703 (99 %) | 2 diff (99.8 %id) | |
| BM725932 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 842 to 1405 | 1 to 564 | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 564/564 (100 %) | 0 diff (100 %id) | ||
| BM728793 | eye, fetal eye | .d | 1016 to 1683 | 1 to 668 | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 668/668 (100 %) | 1 diff (99.9 %id) | ||
| BU742709 | eye, fetal eye | .d | 2203 to 2754 | 568 to 19 | tiling clone, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 550/550 (100 %) | 4 diff (99.3 %id) | |
| CA435325 | lung, Metastatic Chondrosarcoma | .e | 2232 to 2843 | 627 to 16 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 612/624 (98 %) | 1 diff (99.9 %id) | |
| CA437427 | lung, Metastatic Chondrosarcoma | .o | 101 to 649 | 567 to 19 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 549/549 (100 %) | 1 diff (99.9 %id) |
| DB267622 | uterus | .d | 510 to 1090 | 2 to 583 | capped | 582/583 (99 %) | 3 diff (99.5 %id) | ||
| AV702805 | adrenal gland | .b | 1 to 574 | 1 to 574 | tiling clone, | 574/583 (98 %) | 5 diff (99.2 %id) | ||
| AK023733 | placenta | .d | 1175 to 1678 | 1 to 504 | available from FLJ, | 504/504 (100 %) | 2 diff (99.7 %id) | ||
| DA112073 | cerebellum | .d | 822 to 1398 | 1 to 578 | capped | 578/579 (99 %) | 6 diff (99.0 %id) | ||
| CN265536 | embryonic stem cells, cell lines H1, H7, andH9 | .d | 27 to 2754 | 1 to 2728 | RefSeq, | 2728/2728 (100 %) | 0 diff (100 %id) | ||
| CN281494 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .d | 221 to 620 | 1 to 396 | 396/404 (98 %) | 5 diff (98.8 %id) | |||
| AV650907 | corresponding non cancerous liver tissue | .d | 46 to 617 | 1 to 572 | Submitted on the opposite strand, submitted on the opposite strand | 572/582 (98 %) | 2 diff (99.7 %id) | ||
| BY796549 | eye | .d | 539 to 1089 | 2 to 552 | 551/551 (100 %) | 1 diff (99.9 %id) | |||
| AV725349 | hypothalamus | .d | 784 to 1358 | 2 to 577 | Suspected internal deletion, this clone was ignored | 576/576 (100 %) | 1 diff (99.9 %id) | ||
| R77917 | placenta | .d | 35 to 613 | 2 to 580 | 579/579 (100 %) | 0 diff (100 %id) | |||
| R78018 | placenta | .r | 1 to 542 | 2 to 544 | tiling clone, | 543/550 (98 %) | 3 diff (99.5 %id) | ||
| AA496701 | .d | 80 to 638 | 2 to 559 | 558/558 (100 %) | 2 diff (99.7 %id) | ||||
| AA496758 | .d | 82 to 800 | 2 to 729 | 728/731 (99 %) | 12 diff (98.4 %id) | ||||
| AA496702 | .d | 1874 to 2291 | 423 to 1 | 423/425 (99 %) | 11 diff (97.5 %id) | ||||
| AA496759 | .d | 35 to 595 | 2 to 562 | 561/561 (100 %) | 0 diff (100 %id) | ||||
| AI919067 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .d | 1525 to 2067 | 543 to 1 | 543/543 (100 %) | 0 diff (100 %id) | |||
| CK003738 | brain/CNS, Human Brain - Cerebellar Cortex | .d | 71 to 641 | 1 to 570 | 570/570 (100 %) | 6 diff (99.0 %id) | |||
| DA802826 | brain | .d | 82 to 646 | 2 to 566 | capped | 565/565 (100 %) | 0 diff (100 %id) | ||
| DA802862 | brain | .o | 263 to 905 | 1 to 642 | tiling clone, capped | 642/642 (100 %) | 2 diff (99.7 %id) | ||
| DB327023 | brain | .e | 1906 to 2428 | 1 to 522 | 522/522 (100 %) | 1 diff (99.9 %id) | |||
| DA807109 | brain | .l | 617 to 1183 | 704 to 120 | capped | 585/1397 (41 %) | 42 diff (97.0 %id) | ||
| DB327214 | brain | .l | 403 to 1183 | 898 to 121 | 778/1108 (70 %) | 56 diff (95.0 %id) | |||
| AU139981 | placenta | .l | 400 to 1183 | 902 to 126 | capped | 777/1087 (71 %) | 48 diff (95.6 %id) | ||
| AU158247 | placenta | .l | 539 to 1183 | 793 to 131 | 663/1159 (57 %) | 30 diff (97.5 %id) | |||
| TI_1948076106 | .l | 535 to 1183 | 781 to 130 | 652/1149 (56 %) | 34 diff (97.1 %id) | ||||
| BP337071 | coronary artery | .d | 48 to 630 | 1 to 584 | 584/584 (100 %) | 2 diff (99.7 %id) | |||
| BP351600 | .d | 115 to 705 | 1 to 588 | 590/588 (100 %) | 5 diff (99.2 %id) | ||||
| DN992578 | brain, whole brain | .d | 613 to 1227 | 9 to 624 | 616/624 (98 %) | 7 diff (98.9 %id) | |||
| DN992578 | brain, whole brain | .d | 613 to 1227 | 9 to 624 | 616/624 (98 %) | 7 diff (98.9 %id) | |||
| DB058044 | testis | .d | 35 to 570 | 2 to 537 | capped | 536/536 (100 %) | 0 diff (100 %id) | ||
| DB119595 | thymus | .d | 631 to 1168 | 2 to 539 | capped | 538/538 (100 %) | 0 diff (100 %id) | ||
| TI_149280055 | .e | 2060 to 2840 | 909 to 131 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 779/785 (99 %) | 0 diff (100 %id) | ||
| TI_149291739 | .d | 1363 to 2069 | 780 to 80 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 701/702 (99 %) | 7 diff (99.1 %id) | ||
| TI_154009452 | .e | 2232 to 2843 | 706 to 95 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 612/1001 (61 %) | 1 diff (100.0 %id) | ||
| TI_154017013 | .o | 1 to 649 | 760 to 97 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 664/724 (91 %) | 21 diff (97.1 %id) | |
| DB175947 | kidney, tumor tissue | .d | 35 to 613 | 2 to 580 | capped | 579/579 (100 %) | 0 diff (100 %id) | ||
| DB243223 | stomach, tumor tissue | .m | 1 to 578 | 2 to 580 | exact | tiling clone, capped | 579/579 (100 %) | 1 diff (99.9 %id) | |
| BQ022403 | placenta | .e | 2515 to 2840 | 344 to 18 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 327/336 (97 %) | 2 diff (99.5 %id) | |
| BQ025290 | placenta | .e | 2179 to 2840 | 679 to 19 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 661/662 (99 %) | 1 diff (99.9 %id) | |
| BQ011625 | placenta | .o | 244 to 653 | 426 to 17 | exact | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 410/410 (100 %) | 0 diff (100 %id) |
| BU682158 | lung | .d | 1434 to 2069 | 649 to 17 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 633/633 (100 %) | 3 diff (99.6 %id) | |
| BM678039 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 2053 to 2749 | 711 to 16 | tiling clone, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 696/703 (99 %) | 2 diff (99.8 %id) | |
| BM678039 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 2053 to 2749 | 711 to 16 | tiling clone, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 696/703 (99 %) | 2 diff (99.8 %id) | |
| BM725932 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 842 to 1405 | 1 to 564 | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 564/564 (100 %) | 0 diff (100 %id) | ||
| BM725932 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 842 to 1405 | 1 to 564 | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 564/564 (100 %) | 0 diff (100 %id) | ||
| BM728793 | eye, fetal eye | .d | 1016 to 1683 | 1 to 668 | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 668/668 (100 %) | 1 diff (99.9 %id) | ||
| BM728793 | eye, fetal eye | .d | 1016 to 1683 | 1 to 668 | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 668/668 (100 %) | 1 diff (99.9 %id) | ||
| BU742709 | eye, fetal eye | .d | 2203 to 2754 | 568 to 19 | tiling clone, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 550/550 (100 %) | 4 diff (99.3 %id) | |
| BU742709 | eye, fetal eye | .d | 2203 to 2754 | 568 to 19 | tiling clone, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 550/550 (100 %) | 4 diff (99.3 %id) | |
| CA435325 | lung, Metastatic Chondrosarcoma | .e | 2232 to 2843 | 627 to 16 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 612/624 (98 %) | 1 diff (99.9 %id) | |
| CA435325 | lung, Metastatic Chondrosarcoma | .e | 2232 to 2843 | 627 to 16 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 612/624 (98 %) | 1 diff (99.9 %id) | |
| CA437427 | lung, Metastatic Chondrosarcoma | .o | 101 to 649 | 567 to 19 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 549/549 (100 %) | 1 diff (99.9 %id) |
| CA437427 | lung, Metastatic Chondrosarcoma | .o | 101 to 649 | 567 to 19 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 549/549 (100 %) | 1 diff (99.9 %id) |
| DB267622 | uterus | .d | 510 to 1090 | 2 to 583 | capped | 582/583 (99 %) | 3 diff (99.5 %id) |